It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 | Mumbai, Maharashtra, India | ActiveShrim Pharma Private Limited, a active private limited company, was established on 28 March 2012 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52100MH2012PTC228795. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Shilpa Paresh Shah (Director), Vikas Kanaiyalal Modi (Director), Damyanti Vikas Modi (Director). Past directors included Vikas Kanaiyalal Modi, Jayesh Manilal Raiththa. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 37,Maharaja Co-Op Hsg. Society, Opp. Tele Exchange, S.V.Road, Malad (Wes, T), Mumbai, Maharashtra, 400064.
U52100MH2012PTC228795
228795
28 March 2012
₹1.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shrim Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shilpa Paresh Shah | Director | 28 Mar 2012 | Current |
| Vikas Kanaiyalal Modi | Director | 03 Oct 2016 | Current |
| Damyanti Vikas Modi | Director | 28 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 31 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shrim Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 34.36% decrease. The company also saw a substantial fall in profitability, with a 196.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Shrim Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shrim Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shrim Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrim Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shrim Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Shrim Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Vikas Kanaiyalal Modi was appointed as a Director was appointed as a Director on 03 Oct 2016 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
Shilpa Paresh Shah was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 8 months . was recorded as a recent event.
Progress on Damyanti Vikas Modi was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 8 months . was documented.
The activity Shrim Pharma Private Limited was registered on 28 Mar 2012 with Roc Mumbai & aged 13 years 8 months as per MCA records. was completed.
The CIN of Shrim Pharma Private Limited is U52100MH2012PTC228795.
Shrim Pharma Private Limited is headquartered at 37,Maharaja Co-Op Hsg. Society, Opp. Tele Exchange, S.V.Road, Malad (Wes, T), Mumbai, Maharashtra, 400064.
Shrim Pharma Private Limited was incorporated on 28 March 2012.
The current directors of Shrim Pharma Private Limited are
The primary industry of Shrim Pharma Private Limited is Trade.
Shrim Pharma Private Limited is unlisted.
The authorized capital of Shrim Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Shrim Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX